Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866) |
---|
10/23/2001 | US6306629 Genetically engineered microorganism for the generation of preferential compound |
10/23/2001 | US6306628 Methods for the detection, analysis and isolation of Nascent proteins |
10/23/2001 | US6306627 Isolation of the biosynthesis genes for pseudo-oligosaccharides from streptomyces glaucescens GLA.O, and their use |
10/23/2001 | US6306624 Retinoid metabolizing protein |
10/23/2001 | US6306618 Contacting sample with enzyme capable of degrading homocysteine, and determining any reaction product(s) formed |
10/23/2001 | US6306608 Anti-human LECT2 antibody, cells producing the same, and method and kit for assaying the same |
10/23/2001 | US6306605 Methods for making recombinant cells |
10/23/2001 | US6306588 Polymerase with mutation in o-helix domain which reduces ability of enzyme to add non-templated 3' nucleotides to synthesized nucleic acids; genetic engineering; cloning; diagnosis; forensics; plant breeding |
10/23/2001 | US6306583 Human brain phosphodiesterase |
10/23/2001 | US6306579 Immunoassay by incubating sample with at least one peptide from ns3 region having at least one covalently modified cysteine or replaced cysteine, then determining binding of antibody to peptide |
10/23/2001 | US6306402 Compounds and methods for the diagnosis and treatment of EHRLICHIA infection |
10/23/2001 | US6306397 Variants of human papilloma virus antigens |
10/23/2001 | US6306395 Fas antigen derivatives |
10/23/2001 | US6306392 Prevention and/or treatment of alterations of those organs which perform metabolic function, such as liver, kidneys, cardiovascular system and brain; for therapy of hepatosis, nephropathies and cardiovascular or cerebral damage damage |
10/23/2001 | US6306387 Antigen delivery system |
10/23/2001 | US6306345 Drying biological solution or suspension in a chamber by boiling under vacuum to form mechanically stable foam; crushing foam to form powder |
10/23/2001 | CA1341308C Vaccines against avian herpes viruses |
10/23/2001 | CA1341307C Nucleotide sequences of avian herpes viruses |
10/23/2001 | CA1341306C Yeast expression of urokinase-type plasminogen activator and mutants thereof |
10/20/2001 | CA2334103A1 A method for introducing recessive properties into the genetic background of industrial baker's yeast |
10/18/2001 | WO2001077676A1 T2r taste receptors and genes encoding same |
10/18/2001 | WO2001077389A2 Genes expressed in foam cell differentiation |
10/18/2001 | WO2001077374A2 Method for identifying and isolating genome fragments with linkage disequilibrium |
10/18/2001 | WO2001077352A2 Vectors and method for selecting cdna molecules, which comprise an open reading frame |
10/18/2001 | WO2001077348A2 Ketogulonigenium endogenous plasmids |
10/18/2001 | WO2001077347A2 Ketogulonigenium shuttle vectors |
10/18/2001 | WO2001077346A1 Use of the nucleotide sequence of the lactobacillus casei lactose operon promoter for regulating gene expression by means of an antiterminator protein |
10/18/2001 | WO2001077344A1 Vectors |
10/18/2001 | WO2001077342A1 Multivalent antibodies and uses therefor |
10/18/2001 | WO2001077340A1 Identification of a dual specificity phosphatase: dusp-10 |
10/18/2001 | WO2001077339A1 Human pyruvate dehydrogenese phosphatase |
10/18/2001 | WO2001077338A2 Human protein kinases and protein kinase-like enzymes |
10/18/2001 | WO2001077337A1 α1,4-N-ACETYLGALACTOSAMINE TRANSFERASE GENE AND PROCESS FOR PRODUCING THIS ENZYME AND N-ACETYLGALACTOSAMINE-CONTAINING COMPLEX CARBOHYDRATE |
10/18/2001 | WO2001077335A2 Listeria monocytogenes genome, polypeptides and uses |
10/18/2001 | WO2001077334A2 Lactococcus lactis genome, polypeptides and uses |
10/18/2001 | WO2001077332A2 Compositions and methods related to canine igg and canine il-13 receptors |
10/18/2001 | WO2001077327A1 THE HIGH BONE MASS GENE OF 11q13.3 |
10/18/2001 | WO2001077326A1 Novel g protein-coupled receptor protein and dna thereof |
10/18/2001 | WO2001077325A1 Novel g protein-coupled receptor protein and dna thereof |
10/18/2001 | WO2001077323A1 Gene coding for erbin, and diagnostic and therapeutic uses thereof |
10/18/2001 | WO2001077322A1 Cryptic-like secreted protein |
10/18/2001 | WO2001077321A2 Identification of a human gaba transporter |
10/18/2001 | WO2001077315A1 Signal sequence trapping |
10/18/2001 | WO2001077314A1 MODIFIED α2,3-SIALYLTRANSFERASE GENE AND PROCESS FOR PRODUCING α2,3-SIALYLTRANSFERASE AND COMPLEX SACCHARIDE CONTAINING SIALIC ACID |
10/18/2001 | WO2001077313A1 α1,2-FUCOSYLTRANSFERASE AND PROCESS FOR PRODUCING FUCOSE-CONTAINING COMPLEX CARBOHYDRATE |
10/18/2001 | WO2001077312A1 A transformant for screening of inhibitors for human immunodeficiency virus |
10/18/2001 | WO2001077296A1 Method for the selective removal of fermentation inhibitors from biomass hydrolyzate |
10/18/2001 | WO2001077295A1 Mutant bank |
10/18/2001 | WO2001077283A1 Utilization of invertebrate learning for flexible and sensitive monitoring and identification of chemicals |
10/18/2001 | WO2001077174A2 Human transporters and ion channels |
10/18/2001 | WO2001077169A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
10/18/2001 | WO2001077159A2 An endogenous ketogulonigenium plasmid |
10/18/2001 | WO2001077158A1 Hepatitis b core antigen fusion proteins |
10/18/2001 | WO2001077153A2 Phage display selection of anti fungal peptides |
10/18/2001 | WO2001077150A2 Serine-threonine kinase |
10/18/2001 | WO2001077149A2 Regulation of human cyslt2-like gpcr protein |
10/18/2001 | WO2001077148A2 Human lipid binding protein 1 |
10/18/2001 | WO2001077147A2 New bromodomain protein |
10/18/2001 | WO2001077137A1 Albumin fusion proteins |
10/18/2001 | WO2001077094A1 Percyquinnin, a process for its production and its use as a pharmaceutical |
10/18/2001 | WO2001076612A1 METHOD FOR PRODUCING NEMATOCIDAL COMPOSITION BY HEAT TREATING A pH-ADJUSTED FERMENTATION BROTH |
10/18/2001 | WO2001076391A1 Cultured protein hydrolysate |
10/18/2001 | WO2001059450A8 Cells expressing zinc finger protein for drug discovery |
10/18/2001 | WO2001036626A3 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds |
10/18/2001 | WO2001036455A3 Chlamydia antigens and corresponding dna fragments and uses thereof |
10/18/2001 | WO2001025430A3 Novel human membrane proteins |
10/18/2001 | WO2001023540A3 P-glycoproteins and uses thereof |
10/18/2001 | WO2001021825A3 Novel enzymes which dehydrate glycerol |
10/18/2001 | WO2001021809A3 Stachybotrys phenol oxidizing enzyme |
10/18/2001 | WO2001020012A3 Enhanced plant cell transformation by addition of host genes involved in t-dna integration |
10/18/2001 | WO2001020004A3 Protein phosphatase and kinase proteins |
10/18/2001 | WO2001000802A3 Partial sequences of the genes of the primary and secondary metabolism from corynebacterium glutamicum |
10/18/2001 | WO2000037635A3 Genetic suppressor elements against human immunodeficiency virus |
10/18/2001 | US20010032343 Italian rye grass and a method of introducing endophytic funji into an italian rye grass |
10/18/2001 | US20010032052 Apparatus and method for automated protein design |
10/18/2001 | US20010031779 Methods and materials for treating and preventing inflammation of mucosal tissue |
10/18/2001 | US20010031492 Assay reagent |
10/18/2001 | US20010031489 Synthesis and isolation of polylactone polyester biopolymers from recombinant bacteria comprising fragment of poly (hydroxy fatty acid) synthase from Thiocapsa incubated with carbon source |
10/18/2001 | US20010031486 Modification of enzyme by substitution with non-native amino acids to reduce inhibition by purine nucleotide end products |
10/18/2001 | US20010031485 Nucleic acid coding for fusion protein which binds receptor; internalized by endocytosis; inhibits ribosomes and angiogenesis; therapy for tumors, metastasis, eye disorders, chronic inflammation and ischemic injuries |
10/18/2001 | US20010031470 Using the depolymerization of a nucleic acid hybrid to qualitatively and quantitatively analyze for the presence of a predetermined nucleic acid; detection of single nucleotide polymorphisms, speciation, viral load, genotyping |
10/18/2001 | US20010031284 Process for extracting antioxidants from anaerobically fermented solid plant waste and extracts prepared thereby |
10/18/2001 | US20010031268 Neisseria culture |
10/18/2001 | US20010031265 Soaking in solution; then culturing |
10/18/2001 | DE10007234A1 Peptid und dafür kodierende Nukleinsäure zur Bestimmung, Diagnostik und Therapie von Erkrankungen des Nervensystems Peptide and nucleic acid coding for determining diagnosis and treatment of diseases of the nervous system |
10/18/2001 | CA2416118A1 Method for identifying and isolating genome fragments with linkage disequilibrium |
10/18/2001 | CA2406448A1 Identification of a human gaba transporter |
10/18/2001 | CA2406045A1 Method for producing a nematocidal composition by heat treating a ph-adjusted fermentation broth |
10/18/2001 | CA2405912A1 Albumin fusion proteins |
10/18/2001 | CA2405800A1 Novel secreted protein |
10/18/2001 | CA2405730A1 Serine-threonine kinase |
10/18/2001 | CA2405725A1 Identification of a novel dual specificity phosphataes |
10/18/2001 | CA2405181A1 Human pyruvate dehydrogenese phosphatase |
10/18/2001 | CA2405124A1 Gene coding for erbin, and diagnostic and therapeutic uses thereof |
10/18/2001 | CA2405104A1 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
10/18/2001 | CA2405083A1 New bromodomain protein |
10/18/2001 | CA2405066A1 Percyquinnin, a process for its production and its use as a pharmaceutical |
10/18/2001 | CA2404988A1 Listeria monocytogenes genome, polypeptides and uses |
10/18/2001 | CA2404971A1 Human protein kinases and protein kinase-like enzymes |
10/18/2001 | CA2404920A1 Improved process for the conversion of an aqueous biomass hydrolyzate into fuels or chemicals by the selective removal of fermentation inhibitors |